Literature DB >> 582579

Thyroid stimulating antibodies and metastatic thyroid carcinoma.

M H Snow, T Davies, B R Smith, W M Ross, R G Evans, C S Teng, R Hall.   

Abstract

A patient with previously treated follicular carcinoma of the thyroid developed Graves' disease with a high titre of thyroid-stimulating antibodies (TSAb). He developed functioning pulmonary metastases leading to hyperthyroidism. Levels of TSAb paralleled the functional status of the metastases suggesting that hyperfunction of the neoplastic tissues was caused by TSAb.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 582579     DOI： 10.1111/j.1365-2265.1979.tb02097.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  4 in total

1.  Thyroid carcinoma in thyrotoxic patients treated by surgery.

Authors:  F Pacini; R Elisei; G C Di Coscio; S Anelli; E Macchia; R Concetti; P Miccoli; M Arganini; A Pinchera
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

2.  T3 toxicosis due to nonmetastatic follicular carcinoma of the thyroid.

Authors:  A Pont; D Spratt; J B Shinn
Journal:  West J Med       Date:  1982-03

3.  Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.

Authors:  S Basaria; R Salvatori
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

4.  Binding of solubilized human TSH-receptor protein by peripheral blood lymphocytes of patients with Graves' disease.

Authors:  B Wenzel; K W Wenzel; P Kotulla; H Schleusener
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.